Nih consensus development panel on impotence
Nearly 2.2 million patients were prescribed a GLP-1 RA from January 2019 to December 2025, with nearly 11.2 million total prescriptions made during that time
Saxenda, the second to be approved, only achieved middling weight-management results for a large share of those who took it, and physicians were reticent to prescribe weight-loss medications after the disastrous effects of drugs such as fen-phen were revealed in the late 90s
Back Capozzi, ME, DiMarchi, RD, Tschp, MH, et al (13 June 2019) Targeting the incretin/glucagon system with triagonists to treat diabetes', Endocrine Reviews , 39/5, 719-38